Correlation Between Transgene and Cyteir Therapeutics
Can any of the company-specific risk be diversified away by investing in both Transgene and Cyteir Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Transgene and Cyteir Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Transgene SA and Cyteir Therapeutics, you can compare the effects of market volatilities on Transgene and Cyteir Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Transgene with a short position of Cyteir Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Transgene and Cyteir Therapeutics.
Diversification Opportunities for Transgene and Cyteir Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Transgene and Cyteir is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Transgene SA and Cyteir Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cyteir Therapeutics and Transgene is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Transgene SA are associated (or correlated) with Cyteir Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cyteir Therapeutics has no effect on the direction of Transgene i.e., Transgene and Cyteir Therapeutics go up and down completely randomly.
Pair Corralation between Transgene and Cyteir Therapeutics
Assuming the 90 days horizon Transgene SA is expected to generate 9.02 times more return on investment than Cyteir Therapeutics. However, Transgene is 9.02 times more volatile than Cyteir Therapeutics. It trades about 0.04 of its potential returns per unit of risk. Cyteir Therapeutics is currently generating about 0.12 per unit of risk. If you would invest 1.00 in Transgene SA on August 29, 2024 and sell it today you would earn a total of 158.00 from holding Transgene SA or generate 15800.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 31.31% |
| Values | Daily Returns |
Transgene SA vs. Cyteir Therapeutics
Performance |
| Timeline |
| Transgene SA |
| Cyteir Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Transgene and Cyteir Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Transgene and Cyteir Therapeutics
The main advantage of trading using opposite Transgene and Cyteir Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Transgene position performs unexpectedly, Cyteir Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cyteir Therapeutics will offset losses from the drop in Cyteir Therapeutics' long position.| Transgene vs. Compania Cervecerias Unidas | Transgene vs. Silo Pharma | Transgene vs. Skechers USA | Transgene vs. JJill Inc |
| Cyteir Therapeutics vs. Nuvation Bio | Cyteir Therapeutics vs. Foghorn Therapeutics | Cyteir Therapeutics vs. C4 Therapeutics | Cyteir Therapeutics vs. Prelude Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Complementary Tools
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years |